APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hib Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hib Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025183 pages

Choose your research edition.

Industry ResearchHib Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Hib Vaccine Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Hib Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hib Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Hib Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Hib Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hib Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hib Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hib Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hib Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hib Vaccine include Lanzhou Institute, Zhifei Bio, Sanofi Pasteur, Kangtai Bio, Watson Bio, Glaxosmithkline, Olin Bio and Bharat Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hib Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hib Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hib Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hib Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Hib Vaccine Segment by Company

Lanzhou Institute

Zhifei Bio

Sanofi Pasteur

Kangtai Bio

Watson Bio

Glaxosmithkline

Olin Bio

Bharat Biotech

Hib Vaccine Segment by Type

Hib Vaccine

Multiple Seedlings

Hib Vaccine Segment by Application

Hospital

Clinic

Hib Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hib Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hib Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hib Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hib Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hib Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hib Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hib Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hib Vaccine Industry Trends Table 2. Hib Vaccine Industry Drivers Table 3. Hib Vaccine Industry Opportunities and Challenges Table 4. Hib Vaccine Industry Restraints Table 5. Global Hib Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hib Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hib Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Hib Vaccine Sales Market Share by Manufacturers Table 9. Global Hib Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Hib Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hib Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hib Vaccine Manufacturers, Product Type & Application Table 13. Global Hib Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hib Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Hib Vaccine Table 17. Major Manufacturers of Multiple Seedlings Table 18. Global Hib Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Hib Vaccine Sales by Type (2021-2026) & (k units) Table 20. Global Hib Vaccine Sales by Type (2027-2032) & (k units) Table 21. Global Hib Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Hib Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Hib Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Hib Vaccine Revenue by Type (2021-2026) & (k units) Table 25. Global Hib Vaccine Revenue by Type (2027-2032) & (k units) Table 26. Global Hib Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Hib Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global Hib Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Hib Vaccine Sales by Application (2021-2026) & (k units) Table 32. Global Hib Vaccine Sales by Application (2027-2032) & (k units) Table 33. Global Hib Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Hib Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Hib Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Hib Vaccine Revenue by Application (2021-2026) & (k units) Table 37. Global Hib Vaccine Revenue by Application (2027-2032) & (k units) Table 38. Global Hib Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Hib Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Hib Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Hib Vaccine Sales by Region (2021-2026) & (k units) Table 42. Global Hib Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Hib Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Hib Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Hib Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Hib Vaccine Sales by Country (2021-2026) & (k units) Table 47. North America Hib Vaccine Sales by Country (2027-2032) & (k units) Table 48. Europe Hib Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Hib Vaccine Sales by Country (2021-2026) & (k units) Table 50. Europe Hib Vaccine Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Hib Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Hib Vaccine Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Hib Vaccine Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Hib Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Hib Vaccine Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Hib Vaccine Sales by Country (2027-2032) & (k units) Table 57. Global Hib Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Hib Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Hib Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Hib Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Hib Vaccine Revenue Market Share by Region (2027-2032) Table 62. Lanzhou Institute Company Information Table 63. Lanzhou Institute Business Overview Table 64. Lanzhou Institute Hib Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Lanzhou Institute Hib Vaccine Product Portfolio Table 66. Lanzhou Institute Recent Development Table 67. Zhifei Bio Company Information Table 68. Zhifei Bio Business Overview Table 69. Zhifei Bio Hib Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Zhifei Bio Hib Vaccine Product Portfolio Table 71. Zhifei Bio Recent Development Table 72. Sanofi Pasteur Company Information Table 73. Sanofi Pasteur Business Overview Table 74. Sanofi Pasteur Hib Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Sanofi Pasteur Hib Vaccine Product Portfolio Table 76. Sanofi Pasteur Recent Development Table 77. Kangtai Bio Company Information Table 78. Kangtai Bio Business Overview Table 79. Kangtai Bio Hib Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Kangtai Bio Hib Vaccine Product Portfolio Table 81. Kangtai Bio Recent Development Table 82. Watson Bio Company Information Table 83. Watson Bio Business Overview Table 84. Watson Bio Hib Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Watson Bio Hib Vaccine Product Portfolio Table 86. Watson Bio Recent Development Table 87. Glaxosmithkline Company Information Table 88. Glaxosmithkline Business Overview Table 89. Glaxosmithkline Hib Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Glaxosmithkline Hib Vaccine Product Portfolio Table 91. Glaxosmithkline Recent Development Table 92. Olin Bio Company Information Table 93. Olin Bio Business Overview Table 94. Olin Bio Hib Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Olin Bio Hib Vaccine Product Portfolio Table 96. Olin Bio Recent Development Table 97. Bharat Biotech Company Information Table 98. Bharat Biotech Business Overview Table 99. Bharat Biotech Hib Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Bharat Biotech Hib Vaccine Product Portfolio Table 101. Bharat Biotech Recent Development Table 102. Key Raw Materials Table 103. Raw Materials Key Suppliers Table 104. Hib Vaccine Distributors List Table 105. Hib Vaccine Customers List Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. Hib Vaccine Product Image Figure 2. Global Hib Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hib Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Hib Vaccine Sales (2021-2032) & (k units) Figure 5. Global Hib Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hib Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Hib Vaccine Image Figure 9. Multiple Seedlings Image Figure 10. Global Hib Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Hib Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Hib Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Hib Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Hib Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hib Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global Hib Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Hib Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Hib Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Hib Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Hib Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Hib Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Hib Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Hib Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Hib Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Hib Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Hib Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Hib Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Hib Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Hib Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Hib Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Hib Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Hib Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Hib Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Hib Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Hib Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Hib Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Hib Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Hib Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Hib Vaccine
  • Multiple Seedlings
Applications
  • Hospital
  • Clinic
Companies covered
  • Lanzhou Institute
  • Zhifei Bio
  • Sanofi Pasteur
  • Kangtai Bio
  • Watson Bio
  • Glaxosmithkline
  • Olin Bio
  • Bharat Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hib Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hib Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hib Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hib Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hib Vaccine Market Dynamics
  1. 2.1 Hib Vaccine Industry Trends
  2. 2.2 Hib Vaccine Industry Drivers
  3. 2.3 Hib Vaccine Industry Opportunities and Challenges
  4. 2.4 Hib Vaccine Industry Restraints
3 Hib Vaccine Market by Manufacturers
  1. 3.1 Global Hib Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hib Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hib Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hib Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hib Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hib Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Hib Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hib Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hib Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hib Vaccine Tier 1, Tier 2, and Tier 3
4 Hib Vaccine Market by Type
  1. 4.1 Hib Vaccine Type Introduction
  2. 4.1.1 Hib Vaccine
  3. 4.1.2 Multiple Seedlings
  4. 4.2 Global Hib Vaccine Sales by Type
  5. 4.2.1 Global Hib Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hib Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Hib Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Hib Vaccine Revenue by Type
  9. 4.3.1 Global Hib Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hib Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Hib Vaccine Revenue Market Share by Type (2021-2032)
5 Hib Vaccine Market by Application
  1. 5.1 Hib Vaccine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Hib Vaccine Sales by Application
  5. 5.2.1 Global Hib Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Hib Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Hib Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Hib Vaccine Revenue by Application
  9. 5.3.1 Global Hib Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Hib Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Hib Vaccine Revenue Market Share by Application (2021-2032)
6 Global Hib Vaccine Sales by Region
  1. 6.1 Global Hib Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hib Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Hib Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Hib Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hib Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hib Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hib Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hib Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hib Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hib Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hib Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hib Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hib Vaccine Revenue by Region
  1. 7.1 Global Hib Vaccine Revenue by Region
  2. 7.1.1 Global Hib Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hib Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Hib Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Hib Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hib Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Hib Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hib Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Hib Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hib Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hib Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hib Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hib Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Lanzhou Institute
  2. 8.1.1 Lanzhou Institute Company Information
  3. 8.1.2 Lanzhou Institute Business Overview
  4. 8.1.3 Lanzhou Institute Hib Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lanzhou Institute Hib Vaccine Product Portfolio
  6. 8.1.5 Lanzhou Institute Recent Developments
  7. 8.2 Zhifei Bio
  8. 8.2.1 Zhifei Bio Company Information
  9. 8.2.2 Zhifei Bio Business Overview
  10. 8.2.3 Zhifei Bio Hib Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zhifei Bio Hib Vaccine Product Portfolio
  12. 8.2.5 Zhifei Bio Recent Developments
  13. 8.3 Sanofi Pasteur
  14. 8.3.1 Sanofi Pasteur Company Information
  15. 8.3.2 Sanofi Pasteur Business Overview
  16. 8.3.3 Sanofi Pasteur Hib Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Pasteur Hib Vaccine Product Portfolio
  18. 8.3.5 Sanofi Pasteur Recent Developments
  19. 8.4 Kangtai Bio
  20. 8.4.1 Kangtai Bio Company Information
  21. 8.4.2 Kangtai Bio Business Overview
  22. 8.4.3 Kangtai Bio Hib Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Kangtai Bio Hib Vaccine Product Portfolio
  24. 8.4.5 Kangtai Bio Recent Developments
  25. 8.5 Watson Bio
  26. 8.5.1 Watson Bio Company Information
  27. 8.5.2 Watson Bio Business Overview
  28. 8.5.3 Watson Bio Hib Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Watson Bio Hib Vaccine Product Portfolio
  30. 8.5.5 Watson Bio Recent Developments
  31. 8.6 Glaxosmithkline
  32. 8.6.1 Glaxosmithkline Company Information
  33. 8.6.2 Glaxosmithkline Business Overview
  34. 8.6.3 Glaxosmithkline Hib Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Glaxosmithkline Hib Vaccine Product Portfolio
  36. 8.6.5 Glaxosmithkline Recent Developments
  37. 8.7 Olin Bio
  38. 8.7.1 Olin Bio Company Information
  39. 8.7.2 Olin Bio Business Overview
  40. 8.7.3 Olin Bio Hib Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Olin Bio Hib Vaccine Product Portfolio
  42. 8.7.5 Olin Bio Recent Developments
  43. 8.8 Bharat Biotech
  44. 8.8.1 Bharat Biotech Company Information
  45. 8.8.2 Bharat Biotech Business Overview
  46. 8.8.3 Bharat Biotech Hib Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bharat Biotech Hib Vaccine Product Portfolio
  48. 8.8.5 Bharat Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hib Vaccine Value Chain Analysis
  2. 9.1.1 Hib Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hib Vaccine Production Mode & Process
  6. 9.2 Hib Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hib Vaccine Distributors
  9. 9.2.3 Hib Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst